PCMI
GSK icon

Princeton Capital Management Inc’s GSK GSK Stock Holding History

Princeton Capital Management Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,146
Closed -$1.13M – 70
2013
Q2 		$1.13M Buy
+18,146
New +$1.15M 1.09% 38

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Princeton Capital Management Inc's GSK Position: Q3 2013 in Review

Princeton Capital Management Inc sold out of GSK (GSK) in Q3 2013, closing a stake of 18,146 shares — an estimated $1.13M sold.

Princeton Capital Management Inc first reported a position in GSK in Q2 2013 and held it in 1 quarter. The position peaked at $1.13M in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

  • Princeton Capital Management Inc reported no remaining GSK position as of Q3 2013 after selling out during the quarter.
  • Princeton Capital Management Inc sold 18,146 GSK shares in Q3 2013, an estimated $1.13M.
  • Princeton Capital Management Inc first reported a position in GSK in Q2 2013 and held it in 1 quarter.
  • Princeton Capital Management Inc's GSK position peaked at $1.13M in Q2 2013.
  • 635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Princeton Capital Management Inc's 13F filing for Q3 2013, filed 8 Nov 2013.